12:00 AM
 | 
Nov 05, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

QGC001: Phase Ia data

A double-blind, placebo-controlled, French Phase Ia trial in 56 healthy male volunteers showed that single ascending-doses of 10-1,250 mg oral...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >